Laumas Sandeep
SEC-identified person · CIK 1721664 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Unicycive Therapeutics, Inc. UNCY | Director | filed 2021 - 2026 |
| Bioxcel Therapeutics, Inc. BTAI ] | Director | filed 2018 - 2026 |
| Instil Bio, Inc. TIL | CFO and CBO | filed 2021 - 2025 |
| Tharimmune, Inc. THAR | Officer | filed 2022 - 2022 |
| Monster Digital, Inc. NMTR | Director · Executive Chairman | filed 2018 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.